1. Home
  2. WVE vs UTZ Comparison

WVE vs UTZ Comparison

Compare WVE & UTZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WVE
  • UTZ
  • Stock Information
  • Founded
  • WVE 2012
  • UTZ 2018
  • Country
  • WVE Singapore
  • UTZ United States
  • Employees
  • WVE N/A
  • UTZ N/A
  • Industry
  • WVE Biotechnology: Pharmaceutical Preparations
  • UTZ Packaged Foods
  • Sector
  • WVE Health Care
  • UTZ Consumer Staples
  • Exchange
  • WVE Nasdaq
  • UTZ Nasdaq
  • Market Cap
  • WVE 915.6M
  • UTZ 1.1B
  • IPO Year
  • WVE 2015
  • UTZ N/A
  • Fundamental
  • Price
  • WVE $7.35
  • UTZ $9.39
  • Analyst Decision
  • WVE Strong Buy
  • UTZ Buy
  • Analyst Count
  • WVE 14
  • UTZ 7
  • Target Price
  • WVE $20.50
  • UTZ $15.64
  • AVG Volume (30 Days)
  • WVE 3.6M
  • UTZ 1.8M
  • Earning Date
  • WVE 11-10-2025
  • UTZ 10-30-2025
  • Dividend Yield
  • WVE N/A
  • UTZ 2.39%
  • EPS Growth
  • WVE N/A
  • UTZ N/A
  • EPS
  • WVE N/A
  • UTZ 0.04
  • Revenue
  • WVE $109,230,000.00
  • UTZ $1,437,681,000.00
  • Revenue This Year
  • WVE N/A
  • UTZ $3.60
  • Revenue Next Year
  • WVE $6.24
  • UTZ $2.88
  • P/E Ratio
  • WVE N/A
  • UTZ $239.95
  • Revenue Growth
  • WVE 103.75
  • UTZ 1.22
  • 52 Week Low
  • WVE $5.28
  • UTZ $9.48
  • 52 Week High
  • WVE $16.38
  • UTZ $17.78
  • Technical
  • Relative Strength Index (RSI)
  • WVE 49.41
  • UTZ 27.49
  • Support Level
  • WVE $6.60
  • UTZ $9.48
  • Resistance Level
  • WVE $7.27
  • UTZ $9.86
  • Average True Range (ATR)
  • WVE 0.53
  • UTZ 0.38
  • MACD
  • WVE -0.04
  • UTZ -0.03
  • Stochastic Oscillator
  • WVE 51.78
  • UTZ 5.67

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

About UTZ Utz Brands Inc

Utz Brands Inc is a manufacturer of branded salty snacks. It produces a broad offering of salty snacks, including potato chips, tortilla chips, pretzels, cheese snacks, pork skins, pub/party mixes, and other snacks. Its iconic portfolio of authentic, craft, and better-for-you (BFY) brands, which includes Utz, Zapp's, On The Border, Golden Flake, and Boulder Canyon, among others, enjoys household penetration in the United States, where its products can be found in approximately half of U.S. household. The company operates in eight manufacturing facilities with a broad range of capabilities, and its products are distributed nationally to grocery, mass, club, convenience, drug, e-commerce and other retailers through direct shipments, distributors, and approximately 2,500 DSD routes.

Share on Social Networks: